Briumvi
December 4, 2023

FDA approves Briumvi (Ublituximab-Xiiy) for the treatment of relapsing forms of multiple sclerosis (MS) in adults

Briumvi, also known as ublituximab-xiiy, is a medication approved by the FDA for the treatment …

Skyclarys
December 4, 2023

Skyclarys (Omaveloxolone): FDA approves first therapy for Friedreich’s Ataxia in patients aged 16 years and older. 

For individuals living with the rare and devastating disease Friedreich's ataxia (FA), Skyclary…

Daybue
December 1, 2023

Daybue: The sole approved therapy for Rett syndrome for adults and pediatric patient above 2 years. 

Daybue was approved by the U.S. Food and Drug Administration (FDA) on March 13, 2023 for the tr…

Zynyz
December 1, 2023

Zynyz: FDA-Approved Treatment For Merkel Cell Carcinoma In Adult Patient 

Zynyz (retifanlimab-dlwr) received accelerated approval from the FDA On March 22, 2023. The dru…

Rezzayo
December 1, 2023

Rezzayo: A Novel Antifungal for Invasive Candidiasis And Candidemia

A newly developed echinocandin antifungal drug called Rezzayo (rezafungin for injection) is pre…

Joenja
November 30, 2023

FDA Approves Joenja As The First Treatment For APDS

Introduction In the ever-evolving landscape of medical advancements, Joenja has emerged as a…

Qalsody
November 30, 2023

Qalsody: a novel antisense oligonucleotide (ASO) therapy

Qalsody (tofersen), a novel antisense oligonucleotide (ASO) therapy, has emerged as a beacon of…

Elfabrio
November 30, 2023

Elfabrio: FDA-Approved Treatment for Fabry Disease 

Introduction Elfabrio (pegunigalsidase alfa-iwxj) is a medication used for the treatment of …

Miebo
November 29, 2023

Miebo: FDA Approved Treatment for dry eye disease 

Introduction Miebo (perfluorohexyloctane ophthalmic solution) is a prescription eye drop med…

EPKINLY
November 29, 2023

Epkinly (Epcoritamab): FDA Approved Bispecific Antibody DLBCL

Introduction Epkinly (epcoritamab) is a novel bispecific CD20-directed CD3 T-cell engager in…

Xacduro
November 29, 2023

Xacduro: A Breakthrough Treatment for HABP and VABP

Introduction Xacduro (sulbactam/durlobactam) is a combination antibiotic injection used to t…

Ultomiris
November 24, 2023

Ultomiris: A Therapy for Paroxysmal Nocturnal Hemoglobinuria

Introduction and FDA Approval Ultomiris (ravulizumab-cwvy) is a first-in-class, long-acting …

Agrylin
November 24, 2023

Agrylin: A Detailed Overview For Thrombocythemia Treatment

Agrylin, also known as anagrelide hydrochloride, is a prescription medication used to treat thr…

Translarna
November 23, 2023

Translarna: A Treatment for Duchenne Muscular Dystrophy

Translarna (ataluren) is a groundbreaking medication that has emerged as a beacon of hope for i…

naglazyme
November 22, 2023

Naglazyme: Enzyme Replacement Treatment for MPS VI

Naglazyme, also known by its generic name galsulfase, is a breakthrough medication approved by …

×